Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study.

Mehta RL, Burdmann EA, Cerdá J, Feehally J, Finkelstein F, García-García G, Godin M, Jha V, Lameire NH, Levin NW, Lewington A, Lombardi R, Macedo E, Rocco M, Aronoff-Spencer E, Tonelli M, Zhang J, Remuzzi G.

Lancet. 2016 May 14;387(10032):2017-25. doi: 10.1016/S0140-6736(16)30240-9. Epub 2016 Apr 13. Erratum in: Lancet. 2016 May 14;387(10032):1998.

PMID:
27086173
2.

International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology.

Mehta RL, Cerdá J, Burdmann EA, Tonelli M, García-García G, Jha V, Susantitaphong P, Rocco M, Vanholder R, Sever MS, Cruz D, Jaber B, Lameire NH, Lombardi R, Lewington A, Feehally J, Finkelstein F, Levin N, Pannu N, Thomas B, Aronoff-Spencer E, Remuzzi G.

Lancet. 2015 Jun 27;385(9987):2616-43. doi: 10.1016/S0140-6736(15)60126-X. Epub 2015 Mar 13. Review. No abstract available.

PMID:
25777661
3.

Acute kidney injury: an increasing global concern.

Lameire NH, Bagga A, Cruz D, De Maeseneer J, Endre Z, Kellum JA, Liu KD, Mehta RL, Pannu N, Van Biesen W, Vanholder R.

Lancet. 2013 Jul 13;382(9887):170-9. doi: 10.1016/S0140-6736(13)60647-9. Epub 2013 May 31. Review.

PMID:
23727171
4.

How to use biomarkers efficiently in acute kidney injury.

Lameire NH, Vanholder RC, Van Biesen WA.

Kidney Int. 2011 May;79(10):1047-50. doi: 10.1038/ki.2011.21.

5.

Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

Locatelli F, Nissenson AR, Barrett BJ, Walker RG, Wheeler DC, Eckardt KU, Lameire NH, Eknoyan G.

Kidney Int. 2008 Nov;74(10):1237-40. doi: 10.1038/ki.2008.299. Epub 2008 Jul 2.

6.

Costs and length of stay associated with antimicrobial resistance in acute kidney injury patients with bloodstream infection.

Vandijck DM, Blot SI, Decruyenaere JM, Vanholder RC, De Waele JJ, Lameire NH, Claus S, De Schuijmer J, Dhondt AW, Verschraegen G, Hoste EA.

Acta Clin Belg. 2008 Jan-Feb;63(1):31-8.

PMID:
18386763
7.

Health implications of antimicrobial resistance for patients with acute kidney injury and bloodstream infection.

Hoste EA, Vandijck DM, Vanholder RC, De Waele JJ, Lameire NH, Claus S, De Schuijmer J, Dhondt AW, Decruyenaere JM, Verschraegen G, Blot SI.

Infect Control Hosp Epidemiol. 2007 Sep;28(9):1107-10. Epub 2007 Jul 12.

PMID:
17932837
8.

Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia.

De Vriese AS, Tilton RG, Mortier S, Lameire NH.

Nephrol Dial Transplant. 2006 Sep;21(9):2549-55. Epub 2006 Jun 6.

PMID:
16757496
9.

Contrast-induced nephropathy--prevention and risk reduction.

Lameire NH.

Nephrol Dial Transplant. 2006 Jun;21(6):i11-23. Review.

PMID:
16723348
10.

Introduction.

Lameire NH.

Nephrol Dial Transplant. 2006 Jun;21 Suppl 1:i1. No abstract available.

PMID:
16723347
11.

A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat.

Schrijvers BF, Flyvbjerg A, Tilton RG, Lameire NH, De Vriese AS.

Nephrol Dial Transplant. 2006 Feb;21(2):324-9. Epub 2005 Oct 25.

PMID:
16249198
12.

Sodium bicarbonate versus THAM in ICU patients with mild metabolic acidosis.

Hoste EA, Colpaert K, Vanholder RC, Lameire NH, De Waele JJ, Blot SI, Colardyn FA.

J Nephrol. 2005 May-Jun;18(3):303-7.

PMID:
16013019
13.

Pathophysiological role of vascular endothelial growth factor in the remnant kidney.

Schrijvers BF, Flyvbjerg A, Tilton RG, Rasch R, Lameire NH, De Vriese AS.

Nephron Exp Nephrol. 2005;101(1):e9-15. Epub 2005 May 27.

PMID:
15925906
14.

Acute renal failure in cancer patients.

Lameire NH, Flombaum CD, Moreau D, Ronco C.

Ann Med. 2005;37(1):13-25. Review.

PMID:
15902843
15.
16.

Animal models in peritoneal dialysis research: a need for consensus.

Mortier S, Lameire NH, De Vriese AS.

Perit Dial Int. 2005 Jan-Feb;25(1):16-24. Review.

PMID:
15770920
17.

Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes.

Schrijvers BF, De Vriese AS, Tilton RG, Van de Voorde J, Denner L, Lameire NH, Flyvbjerg A.

Horm Metab Res. 2005 Jan;37(1):21-5.

PMID:
15702434
18.

Assessment of renal function in recently admitted critically ill patients with normal serum creatinine.

Hoste EA, Damen J, Vanholder RC, Lameire NH, Delanghe JR, Van den Hauwe K, Colardyn FA.

Nephrol Dial Transplant. 2005 Apr;20(4):747-53. Epub 2005 Feb 8.

PMID:
15701668
19.

Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies.

Benoit DD, Hoste EA, Depuydt PO, Offner FC, Lameire NH, Vandewoude KH, Dhondt AW, Noens LA, Decruyenaere JM.

Nephrol Dial Transplant. 2005 Mar;20(3):552-8. Epub 2005 Jan 25.

PMID:
15671075
20.

Creatine supplementation does not decrease total plasma homocysteine in chronic hemodialysis patients.

Taes YE, Delanghe JR, De Bacquer D, Langlois M, Stevens L, Geerolf I, Lameire NH, De Vriese AS.

Kidney Int. 2004 Dec;66(6):2422-8.

21.

Lipid and apoprotein changes during atorvastatin up-titration in hemodialysis patients with hypercholesterolemia: a placebo-controlled study.

Lins RL, Matthys KE, Billiouw JM, Dratwa M, Dupont P, Lameire NH, Peeters PC, Stolear JC, Tielemans C, Maes B, Verpooten GA, Ducobu J, Carpentier YA.

Clin Nephrol. 2004 Oct;62(4):287-94.

PMID:
15524059
22.

Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines and Dialysis Outcomes and Practice Patterns Study (DOPPS) findings.

Locatelli F, Pisoni RL, Akizawa T, Cruz JM, DeOreo PB, Lameire NH, Held PJ.

Am J Kidney Dis. 2004 Nov;44(5 Suppl 2):27-33.

PMID:
15486871
23.

Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.

Mortier S, Faict D, Schalkwijk CG, Lameire NH, De Vriese AS.

Kidney Int. 2004 Sep;66(3):1257-65.

24.

In vitro study of the potential role of guanidines in leukocyte functions related to atherogenesis and infection.

Glorieux GL, Dhondt AW, Jacobs P, Van Langeraert J, Lameire NH, De Deyn PP, Vanholder RC.

Kidney Int. 2004 Jun;65(6):2184-92.

25.

Effect of dietary creatine on skeletal muscle myosin heavy chain isoform expression in an animal model of uremia.

Taes YE, Speeckaert M, Bauwens E, De Buyzere MR, Libbrecht J, Lameire NH, Delanghe JR.

Nephron Exp Nephrol. 2004;96(4):e103-10.

PMID:
15122059
26.

The effects of peritoneal dialysis solutions on peritoneal host defense.

Mortier S, Lameire NH, De Vriese AS.

Perit Dial Int. 2004 Mar-Apr;24(2):123-38. Review.

PMID:
15119633
27.

Endothelium-derived hyperpolarizing factor-mediated renal vasodilatory response is impaired during acute and chronic hyperhomocysteinemia.

De Vriese AS, Blom HJ, Heil SG, Mortier S, Kluijtmans LA, Van de Voorde J, Lameire NH.

Circulation. 2004 May 18;109(19):2331-6. Epub 2004 Apr 26.

PMID:
15117854
28.

Systemic and splanchnic haemodynamic effects of sildenafil in an in vivo animal model of cirrhosis support for a risk in cirrhotic patients.

Colle I, De Vriese AS, Van Vlierberghe H, Lameire NH, DeVos M.

Liver Int. 2004 Feb;24(1):63-8.

PMID:
15102002
29.

Vascular hyporesponsiveness in the mesenteric artery of anaesthetized rats with cirrhosis and portal hypertension: an in-vivo study.

Colle IO, De Vriese AS, Van Vlierberghe HR, Lameire NH, De Vos MM.

Eur J Gastroenterol Hepatol. 2004 Feb;16(2):139-45.

PMID:
15075986
30.

Long-term renal changes in the Goto-Kakizaki rat, a model of lean type 2 diabetes.

Schrijvers BF, De Vriese AS, Van de Voorde J, Rasch R, Lameire NH, Flyvbjerg A.

Nephrol Dial Transplant. 2004 May;19(5):1092-7. Epub 2004 Feb 19.

PMID:
14993490
31.

Pathophysiology of ischaemic acute renal failure.

Lameire NH, Vanholder R.

Best Pract Res Clin Anaesthesiol. 2004 Mar;18(1):21-36. Review.

PMID:
14760872
32.

Effect of nosocomial bloodstream infection on the outcome of critically ill patients with acute renal failure treated with renal replacement therapy.

Hoste EA, Blot SI, Lameire NH, Vanholder RC, De Bacquer D, Colardyn FA.

J Am Soc Nephrol. 2004 Feb;15(2):454-62.

33.

Prevention and nondialytic treatment of acute renal failure.

Lameire NH, De Vriese AS, Vanholder R.

Curr Opin Crit Care. 2003 Dec;9(6):481-90. Review.

PMID:
14639067
34.

Creatine supplementation decreases homocysteine in an animal model of uremia.

Taes YE, Delanghe JR, De Vriese AS, Rombaut R, Van Camp J, Lameire NH.

Kidney Int. 2003 Oct;64(4):1331-7.

35.

Antibiotic administration in an animal model of chronic peritoneal dialysate exposure.

Mortier S, De Vriese AS, Leyssens A, Vanacker NJ, Faict D, Cornelissen M, De Ridder L, Lameire NH.

Perit Dial Int. 2003 Jul-Aug;23(4):331-8.

PMID:
12968840
36.

Inhibition of the interaction of AGE-RAGE prevents hyperglycemia-induced fibrosis of the peritoneal membrane.

De Vriese AS, Flyvbjerg A, Mortier S, Tilton RG, Lameire NH.

J Am Soc Nephrol. 2003 Aug;14(8):2109-18.

37.

Effects of conventional and new peritoneal dialysis fluids on leukocyte recruitment in the rat peritoneal membrane.

Mortier S, De Vriese AS, McLoughlin RM, Topley N, Schaub TP, Passlick-Deetjen J, Lameire NH.

J Am Soc Nephrol. 2003 May;14(5):1296-306.

38.

Pharmacokinetics of atorvastatin and its metabolites after single and multiple dosing in hypercholesterolaemic haemodialysis patients.

Lins RL, Matthys KE, Verpooten GA, Peeters PC, Dratwa M, Stolear JC, Lameire NH.

Nephrol Dial Transplant. 2003 May;18(5):967-76.

PMID:
12686673
39.

Acute renal failure in patients with sepsis in a surgical ICU: predictive factors, incidence, comorbidity, and outcome.

Hoste EA, Lameire NH, Vanholder RC, Benoit DD, Decruyenaere JM, Colardyn FA.

J Am Soc Nephrol. 2003 Apr;14(4):1022-30.

40.

Exercise-induced myocardial ischemia is accompanied by increased serum creatine concentrations.

Taes YE, Lameire NH, De Buyzere ML, Shoja A, De Backer G, Delanghe JR.

Clin Chem. 2003 Apr;49(4):684-6. No abstract available.

41.

Studies on dialysate mixing in the Genius single-pass batch system for hemodialysis therapy.

Dhondt AW, Vanholder RC, De Smet RV, Claus SA, Waterloos MA, Glorieux GL, Delanghe JR, Lameire NH.

Kidney Int. 2003 Apr;63(4):1540-7.

42.

Creatine supplementation does not affect kidney function in an animal model with pre-existing renal failure.

Taes YE, Delanghe JR, Wuyts B, van de Voorde J, Lameire NH.

Nephrol Dial Transplant. 2003 Feb;18(2):258-64.

PMID:
12543878
43.

The effects of heparin administration in an animal model of chronic peritoneal dialysate exposure.

De Vriese AS, Mortier S, Cornelissen M, Palmans E, Vanacker NJ, Leyssens A, Faict D, De Ridder L, Lameire NH.

Perit Dial Int. 2002 Sep-Oct;22(5):566-72.

PMID:
12455567
44.

No early respiratory benefit with CVVHDF in patients with acute renal failure and acute lung injury.

Hoste EA, Vanholder RC, Lameire NH, Roosens CD, Decruyenaere JM, Blot SI, Colardyn FA.

Nephrol Dial Transplant. 2002 Dec;17(12):2153-8.

PMID:
12454226
45.

Comparison of the radioiodinated serum albumin (RISA) dilution technique with direct volumetric measurements in animal models of peritoneal dialysis.

Van Biesen W, De Vriese AS, Carlsson O, Van Landschoot M, Dheuvaert T, Lameire NH.

Perit Dial Int. 2002 May-Jun;22(3):316-22. Erratum in: Perit Dial Int. 2002 Nov-Dec;22(6):739.. Devriese An S [corrected to De Vriese An S].

PMID:
12227388
46.

Serum cystatin C concentration compared with other markers of glomerular filtration rate in the old old.

Van Den Noortgate NJ, Janssens WH, Delanghe JR, Afschrift MB, Lameire NH.

J Am Geriatr Soc. 2002 Jul;50(7):1278-82.

PMID:
12133025
47.

Renal function in the oldest-old on an acute geriatric ward.

Van den Noortgate NJ, Janssens WH, Afschrift MB, Lameire NH.

Int Urol Nephrol. 2001;32(4):531-7.

PMID:
11989541
48.

Influence of dialysate on gastric emptying time in peritoneal dialysis patients.

Van V, Schoonjans RS, Struijk DG, Verbanck JJ, Vanholder RC, Van B, Lefebvre RA, De V, Lameire NH.

Perit Dial Int. 2002 Jan-Feb;22(1):32-8.

PMID:
11929141
49.

Is folate a promising agent in the prevention and treatment of cardiovascular disease in patients with renal failure?

De Vriese AS, Verbeke F, Schrijvers BF, Lameire NH.

Kidney Int. 2002 Apr;61(4):1199-209. Review.

50.

What happens to the peritoneal membrane in long-term peritoneal dialysis?

De Vriese AS, Mortier S, Lameire NH.

Perit Dial Int. 2001;21 Suppl 3:S9-18. Review. No abstract available.

PMID:
11887871

Supplemental Content

Loading ...
Support Center